Cargando…

Cycling Quiescence in Temozolomide Resistant Glioblastoma Cells Is Partly Explained by microRNA-93 and -193-Mediated Decrease of Cyclin D

Glioblastoma multiforme (GBM) is a fatal malignancy of the central nervous system, commonly associated with chemoresistance. The alkylating agent Temozolomide (TMZ) is the front-line chemotherapeutic agent and has undergone intense studies on resistance. These studies reported on mismatch repair gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munoz, Jessian L., Walker, Nykia D., Mareedu, Satvik, Pamarthi, Sri Harika, Sinha, Garima, Greco, Steven J., Rameshwar, Pranela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395452/ https://www.ncbi.nlm.nih.gov/pubmed/30853911 http://dx.doi.org/10.3389/fphar.2019.00134

Ejemplares similares

Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level
por: Munoz, Jessian L., et al.
Publicado: (2015)

Restoration of aged hematopoietic cells by their young counterparts through instructive microvesicles release
por: Greco, Steven J., et al.
Publicado: (2021)

Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
por: Munoz, Jessian L, et al.
Publicado: (2013)

A Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All Cancers
por: Nahas, George R., et al.
Publicado: (2015)

A Review of Stem Cell Translation and Potential Confounds by Cancer Stem Cells
por: Bibber, Bernadette, et al.
Publicado: (2013)

Specific N-cadherin–dependent pathways drive human breast cancer dormancy in bone marrow
por: Sinha, Garima, et al.
Publicado: (2021)

Forging New Therapeutic Targets: Efforts of Tumor Derived Exosomes to Prepare the Pre-Metastatic Niche for Cancer Cell Dissemination and Dormancy
por: Bhatia, Ranvir, et al.
Publicado: (2023)

Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies
por: Greco, Steven J, et al.
Publicado: (2008)

Cyclin E1 regulates hematopoietic stem cell quiescence
por: Jayapal, Senthil Raja, et al.
Publicado: (2013)

Abnormal Calcium Handling in Duchenne Muscular Dystrophy: Mechanisms and Potential Therapies
por: Mareedu, Satvik, et al.
Publicado: (2021)

Exosomes from differentially activated macrophages influence dormancy or resurgence of breast cancer cells within bone marrow stroma
por: Walker, Nykia D., et al.
Publicado: (2019)

Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease
por: Xie, Lai-Hua, et al.
Publicado: (2022)

Cancer stem cell gene profile getting closer to the clinic to enhance precise treatment
por: Rameshwar, Pranela
Publicado: (2019)

ATR activity controls stem cell quiescence via the cyclin F–SCF complex
por: Salvi, Jayesh S., et al.
Publicado: (2022)

A method to generate human mesenchymal stem cell-derived neurons which express and are excited by multiple neurotransmitters
por: Greco, Steven J, et al.
Publicado: (2008)

Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43
por: Munoz, J L, et al.
Publicado: (2014)

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer
por: Kaukoniemi, Kirsi M, et al.
Publicado: (2015)

Identification of Novel Subcellular Localization and Trafficking of HIV-1 Nef Variants from Reference Strains G (F1.93.HH8793) and H (BE.93.VI997)
por: Van Nynatten, Logan R., et al.
Publicado: (2018)

WOX5 Suppresses CYCLIN D Activity to Establish Quiescence at the Center of the Root Stem Cell Niche
por: Forzani, Celine, et al.
Publicado: (2014)

MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide
por: Chen, Rui, et al.
Publicado: (2016)

Downregulation of miR-193a-3p via targeting cyclin D1 in thyroid cancer
por: Li, Xiao-Jiao, et al.
Publicado: (2020)

Stem cell in alternative treatments for brain tumors: potential for gene delivery
por: Mariotti, Veronica, et al.
Publicado: (2014)

Investigating Breast Cancer Cell Behavior Using Tissue Engineering Scaffolds
por: Guiro, Khadidiatou, et al.
Publicado: (2015)

The $^{191,193}$Hg and $^{191,193}$Au positon decays
por: Vieu, C, et al.
Publicado: (1976)

An in vitro method to study the effects of hematopoietic regulators during immune and blood cell development
por: Patel, Nitixa, et al.
Publicado: (2007)

MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1
por: Liu, Yunfu, et al.
Publicado: (2017)

DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
por: Thompson, Benjamin J., et al.
Publicado: (2015)

Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse
por: Corvaisier, Matthieu, et al.
Publicado: (2016)

An in vitro method to select malignant cells from surgical biopsies of breast cancer patients
por: Corcoran, Kelly E., et al.
Publicado: (2005)

Multipotent to Pluripotent Properties of Adult Stem Cells
por: Bhartiya, Deepa, et al.
Publicado: (2013)

The Immune Properties of Mesenchymal Stem Cells
por: Castillo, Marianne, et al.
Publicado: (2007)

Monitoring Spontaneous Quiescence and Asynchronous Proliferation-Quiescence Decisions in Prostate Cancer Cells
por: Pulianmackal, Ajai J., et al.
Publicado: (2021)

Effect of densely ionizing radiation on cardiomyocyte differentiation from human‐induced pluripotent stem cells
por: Baljinnyam, Erdene, et al.
Publicado: (2017)

MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells
por: Wang, Hongqin, et al.
Publicado: (2019)

LIN92#19.3
Publicado: (1993)

AB193. Rectourethral fistula
por: Jiang, Hai
Publicado: (2016)

Health Tract, No. 193: Bread
Publicado: (1865)

Health Tract, No. 193: Bread
Publicado: (1864)

Verrucarin J inhibits ovarian cancer and targets cancer stem cells
por: Carter, Kelsey, et al.
Publicado: (2017)

Increased expression of musashi 1 on breast cancer cells has implication to understand dormancy and survival in bone marrow
por: Nahas, George R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hafajtv0kbm9rgtblm7qt3u9ai